Contractor
REGENERON PHARMACEUTICALS INC
TARRYTOWN, NY
- UEI
- N3F9MH7E6HD6
- Parent UEI
- N3F9MH7E6HD6
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$1,261,006,2071
Awards
4
Agencies served
2
Active from Sep 21, 2017 to Oct 5, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79721D0169 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | May 18, 2021 | — |
| HHSO100201700016C IGF::OT::IGF | Department of Health and Human Services | NY | Sep 28, 2017 | $973,560,407 |
| HHSO100201700020C IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD | Department of Health and Human Services | NY | Sep 21, 2017 | $278,844,172 |
| HHSO100201600023C REGENERON ANTI-MERS ANTIBODY THERAPEUTICS PROGRAM DEVELOPMENT | Department of Health and Human Services | NY | Mar 19, 2026 | $8,601,629 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier N3F9MH7E6HD6, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.